The Clinical Times
The Front Page of Medicine

Latest medical news · page 158

The latest headlines across every section, pulled from official and open-access sources.

ACC (Cardiology) · Jun 23, 2026

Genotype Independently Predicts HF Outcomes in Patients With HCM

In patients with hypertrophic cardiomyopathy (HCM), genotype, peak VO2, log NT-proBNP and LVEF independently predict heart failure (HF) outcomes, and combining these measures identified patients at higher risk of HF-related death or transplant, according to a recent study published in JACC: Heart Failure.

UKHSA (UK) · Jun 23, 2026

Accredited official statistics: Monthly mandatory surveillance of MRSA, MSSA, Gram-negative bacteraemia and C. difficile infections, May 2025 to May 2026

Mandatory surveillance of healthcare-associated infections (HCAI), which include methicillin-resistant Staphylococcus aureus (MRSA), Methicillin-sensitive Staphylococcus aureus (MSSA), Gram-negative bacteraemia such as Escherichia coli (E. coli), Klebsiella and Pseudomonas aeruginosa (P. aeruginosa) and Clostridioides difficile (C. difficile, or CDI): May 2025 to May 2026.

FDA Drugs · Jun 23, 2026

FDA Approves First Generic of Priftin (rifapentine) Tablets

The U.S. Food and Drug Administration has approved the first generic of Priftin (rifapentine) tablets, a medication for the treatment of active pulmonary tuberculosis (TB) caused by Mycobacterium tuberculosis in combination with one or more antituberculosis drugs.

PLOS Medicine · Jun 23, 2026

Comparisons of core component delivery in cardiac rehabilitation programs by country income classification and decade based on the 2025 Global Audit Update: A survey study

by Gabriela Lima de Melo Ghisi, Rachael P. Carson, Karam Turk Adawi, Rongjing Ding, Warner M. Mampuya, Mariya P. Jiandani, Jimena Martinez, Monserrat Cruz Rivero, Claudia V. Anchique, Dinah L. van Schalkwijk, Jonathan Gallagher, Buket Akinci, Dion Candelaria, Jirapa Champaiboon, Daniel F. Quesada-Chaves, Tone M. Norekvål, Iwona Szadkowska, Borut Jug, Evangelia Kouidi, Marta Supervia, Won-Seok Kim, Chamila Mettananda, Lilian Mbau, Gulsim T. Aimakova, Sherry L. Grace, on behalf of the ICCPR Global Cardiac Rehabilitation Audit Update Investigators Background Cardiovascular disease (CVD) remains a…

PLOS Medicine · Jun 23, 2026

Parental body mass index and offspring childhood body size and eating behaviour: A structural equation modelling analysis in the Norwegian Mother, Father and Child Cohort Study

by Tom A. Bond, Tom A. McAdams, Nicole M. Warrington, Laurie J. Hannigan, Espen Moen Eilertsen, Ziada Ayorech, Fartein A. Torvik, George Davey Smith, Deborah A. Lawlor, Eivind Ystrom, Alexandra Havdahl, David M. Evans Background The intergenerational transmission of obesity-related traits could propagate an accelerating cycle of obesity, if parental adiposity causally influences offspring adiposity. The extent to which intergenerational obesity associations are due to such causal effects, as opposed to genetic confounding (inheritance), is unclear. We aimed to establish whether associations…

PLOS Medicine · Jun 23, 2026

Prevalence and epidemiological patterns of Neisseria gonorrhoeae infection in sub-Saharan Africa, 1964–2025: Systematic review, meta-analyses, and meta-regressions

by Aisha Osman, Hina Akram, Bayan Alemrayat, Sumaya Al-Maraghi, Manale Harfouche, Laith J. Abu-Raddad Background Neisseria gonorrhoeae (NG) infection is a global health concern because of its morbidity and increasing antimicrobial resistance. Sub-Saharan Africa is believed to carry a disproportionately high burden of NG infection, but the epidemiology of NG infection in this region has not been comprehensively synthesized. This study systematically reviewed and analyzed NG prevalence in sub-Saharan Africa to characterize prevalence patterns and identify populations at risk. Methods and…

PLOS Medicine · Jun 23, 2026

Multi-omics biomarkers of endothelial dysregulation preceding chronic lung allograft dysfunction: A prospective cohort study

by Giulia Iacono, Christina Begka, Bailey Cardwell, Carmel Daunt, Roxanne Chatzis, Celine Pattaroni, Alana Butler, Matthew Macowan, Bronwyn Levvey, Gregory I. Snell, Glen P. Westall, Benjamin J. Marsland Background Long-term survival of lung transplant recipients remains limited by chronic lung allograft dysfunction (CLAD). CLAD is only diagnosed following a persistent and substantial decline in lung function, after which irreversible damage to the lungs has occurred, limiting opportunities to effectively intervene at an early stage. There is a critical need for earlier detection prior to its…

MedCity News · Jun 23, 2026

Why Healthcare AI is Missing the Point

Organizations that are experiencing significant improvements related to AI are not necessarily using more advanced tools. They are just using the tools they have with more intention. The post Why Healthcare AI is Missing the Point appeared first on MedCity News .

MedCity News · Jun 23, 2026

Ibogaine and SUD Treatment: Signal, Risk, and the Role of Providers

Providers don’t need to endorse ibogaine treatment to take this moment seriously. They need to understand it, respect the risk, and prepare for those already seeking it. The post Ibogaine and SUD Treatment: Signal, Risk, and the Role of Providers appeared first on MedCity News .

MedCity News · Jun 23, 2026

Washington’s Medical Debt Push Risks Missing the Bigger Healthcare Crisis

This is not an abstract discussion. It is about sustaining the organizations, employees, and communities that depend on us. If we fail to account for how these policies interact in the real world, we risk weakening the very system we are trying to improve. The post Washington’s Medical Debt Push Risks Missing the Bigger Healthcare Crisis appeared first on MedCity News .

MedCity News · Jun 23, 2026

Why So Few Appeals Happen and What That Reveals About Health Plans

Appeals and grievances reflect how well a health plan functions under pressure. They also show how effectively your organization can surface, prioritize, and resolve the cases that matter most. The post Why So Few Appeals Happen and What That Reveals About Health Plans appeared first on MedCity News .

MedlinePlus (NLM) · Jun 23, 2026

About Group A Strep Infection

Source: Centers for Disease Control and Prevention Related MedlinePlus Pages: Streptococcal Infections

FDA Drugs · Jun 23, 2026

Competitive Generic Therapy Approvals

Explore the FDA’s Competitive Generic Therapy Approvals page, offering insights into the program designed to encourage generic drug competition. Access information about approved CGT products and find resources, including a downloadable CGT approvals spreadsheet.

MedlinePlus (NLM) · Jun 23, 2026

About Group B Strep Disease

Source: Centers for Disease Control and Prevention Related MedlinePlus Pages: Streptococcal Infections

← NewerOlder →

Back to the live front page